false
0001812360
0001812360
2026-03-18
2026-03-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date Earliest Event Reported): March 18, 2026
FOXO
TECHNOLOGIES INC.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-39783 |
|
85-1050265 |
(State
or Other Jurisdiction
of
Incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
477
South Rosemary Avenue
Suite
224
West
Palm Beach, FL |
|
33401 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
(612)
800-0059
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| N/A |
|
|
|
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item
5.02 |
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On
March 18, 2026, Sylwia Nowak Hauman resigned from her position as Chief Financial Officer (Principal Financial and Accounting Officer)
of FOXO Technologies Inc., a Delaware corporation (the “Company”). Ms. Hauman’s
resignation letter cited concerns regarding the Company’s internal control environment, financial reporting processes, and the resourcing
of the finance and accounting team. The Company respectfully disagrees with the characterizations in Ms. Hauman’s resignation letter
and believes the Company’s internal controls, reporting processes and staffing are adequate and have been significantly improved
under current management. The Company remains committed to maintaining strong internal controls and fulfilling its reporting obligations
in a timely manner as will be demonstrated by filing the upcoming 10-K timely.
On
March 24, 2026, the Company appointed Celene Laurene Rattray Grant (age 44) as the Company’s Chief Financial Officer (Principal
Financial and Accounting Officer).
Celene
Grant is a Certified Public Accountant with over 15 years of experience in financial management, business leadership, and corporate strategy,
with particular expertise in the healthcare industry.
Ms.
Grant began her engagement with the Company’s predecessor as a consultant Financial Controller in April 2018, a role she held through
June 2021. She then joined Certified Foot and Ankle Specialists as Chief Accounting Officer, serving in that capacity from June 2021
through February 2024. Ms. Grant returned to FOXO Technologies in April 2024 as a consultant, where she played a key role in returning
the Company to good standing with its SEC reporting obligations, through November 2025. Most recently, from November 2025 until her appointment
as Chief Financial Officer, Ms. Grant has been engaged with Rennova Health Inc., leading efforts to bring that company into compliance
with SEC reporting requirements.
Ms.
Grant holds a Bachelor of Science in Accounting from Florida Atlantic University and a Master of Business Administration from Nova Southeastern
University.
There
are no family relationships between Ms. Grant and any director, executive officer, or person nominated or chosen by the Company to become
a director or executive officer.
There
are no transactions between Ms. Grant and the Company that would require disclosure under Item 404(a) of Regulation S-K.
Ms. Grant will receive an annual base salary of $200,000 and will be eligible
for a discretionary annual bonus of up to $25,000.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
FOXO
Technologies Inc. |
| |
|
|
| Date:
March 24, 2026 |
By: |
/s/
Seamus Lagan |
| |
Name: |
Seamus
Lagan |
| |
Title: |
Chief
Executive Officer |